https://www.selleckchem.com/pr....oducts/Vorinostat-sa
ticoid-based therapies should be prescribed with caution in populations with AD risk. The prevalence of obesity is high and increasing worldwide. Obesity is generally associated with an increased risk of chronic disease and mortality. The objective of the study was to test the effect of a lifestyle intervention on body weight and other chronic disease risk markers. A non-randomized controlled trial was conducted, including mostly middle-aged and elderly participants recruited from the general population in rural northwest German
Like
Comment
Share
